PharmiWeb

New Research on Memantine Market - Side Effects, Drug Interactions, Warning and precautions | Detailed Study by Coherent Market Insights with Upcoming Trends

Memantine is a non-acetyl cholinesterase inhibitor that helps in Alzheimer's disease therapy. The medicine was approved for sale in Europe in 2002 and the United States Food and Drug Administration ...
Nature

Memantine hydrochloride

Memantine hydrochloride (Namenda; Forest/Merz), which acts to protect neurons against toxicity caused by overactivation of N-methyl-D-aspartate receptors, became the first drug to be approved by the ...
Medscape

FDA Approves Extended-Release Memantine for Moderate to Severe Dementia of the Alzheimer's Type

June 22, 2010 — Forest Laboratories Inc and Merz Pharmaceuticals GmbH announced yesterday they have received approval from the US Food and Drug Administration of an extended-release formulation of ...
FierceBiotech

Forest and Merz Announce FDA Approval of NAMENDA XR for the Treatment of Moderate to Severe Dementia of the Alzheimer's Type

Forest and Merz Announce FDA Approval of NAMENDA XR for the Treatment of Moderate to Severe Dementia of the Alzheimer's Type NEW YORK, Jun 21, 2010 (BUSINESS WIRE ...